P Coser

1.6k total citations
38 papers, 914 citations indexed

About

P Coser is a scholar working on Hematology, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, P Coser has authored 38 papers receiving a total of 914 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Hematology, 15 papers in Pathology and Forensic Medicine and 13 papers in Genetics. Recurrent topics in P Coser's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (7 papers). P Coser is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (11 papers) and Acute Lymphoblastic Leukemia research (7 papers). P Coser collaborates with scholars based in Italy, Germany and Austria. P Coser's co-authors include A Congiu, L Mangoni, Angelo Michele Carella, G Broccia, Manfred Mitterer, Giovanna Meloni, Tiziano Barbui, Giuseppe Cimino, Giuseppe Visani and Patrizio Mazza and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

P Coser

37 papers receiving 875 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Coser Italy 15 490 339 324 215 154 38 914
E. Papageorgiou Greece 20 341 0.7× 278 0.8× 252 0.8× 220 1.0× 131 0.9× 48 866
C.F. LeMaistre United States 15 451 0.9× 367 1.1× 230 0.7× 176 0.8× 133 0.9× 27 829
Jean-Philippe Laporte France 12 486 1.0× 431 1.3× 492 1.5× 296 1.4× 139 0.9× 13 1.0k
SH Nantel Canada 13 473 1.0× 283 0.8× 366 1.1× 268 1.2× 128 0.8× 20 847
Mitchell A. Bitter United States 14 556 1.1× 260 0.8× 398 1.2× 231 1.1× 178 1.2× 23 1.1k
Katsumichi Fujimaki Japan 19 419 0.9× 330 1.0× 303 0.9× 254 1.2× 153 1.0× 85 1.1k
Takafumi Matsushima Japan 17 417 0.9× 200 0.6× 266 0.8× 263 1.2× 209 1.4× 57 933
J. L. Harousseau France 14 436 0.9× 293 0.9× 187 0.6× 163 0.8× 133 0.9× 35 812
G. J. Ossenkoppele Netherlands 18 309 0.6× 308 0.9× 269 0.8× 135 0.6× 218 1.4× 51 832
G. Nedellec France 13 362 0.7× 336 1.0× 404 1.2× 292 1.4× 63 0.4× 32 924

Countries citing papers authored by P Coser

Since Specialization
Citations

This map shows the geographic impact of P Coser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Coser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Coser more than expected).

Fields of papers citing papers by P Coser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Coser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Coser. The network helps show where P Coser may publish in the future.

Co-authorship network of co-authors of P Coser

This figure shows the co-authorship network connecting the top 25 collaborators of P Coser. A scholar is included among the top collaborators of P Coser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Coser. P Coser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knop, Stefan, Holger Hebart, Hannes Wandt, et al.. (2007). A Randomized Comparison of Total-Marrow Irradiation, Busulfan and Cyclophosphamide with Tandem High-Dose Melphalan in Patients with Multiple Myeloma.. Blood. 110(11). 728–728. 5 indexed citations
2.
3.
Svaldi, Mirija, et al.. (2002). Transient Myeloproliferative Disorder With a CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Phenotype in a Newborn. Journal of Pediatric Hematology/Oncology. 24(5). 394–396. 1 indexed citations
4.
Billio, Atto, et al.. (2002). A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.. PubMed. 87(5). ECR15–ECR15. 6 indexed citations
5.
Mitterer, Manfred, Mirija Svaldi, Fuat Oduncu, et al.. (2001). Peripheral Blood Monoclonal B-Cells Predict the Event Free Survival in Multiple Myeloma. Leukemia & lymphoma. 41(3-4). 387–395. 9 indexed citations
6.
7.
Billio, Atto, Norbert Pescosta, Giovanni Franco Zanon, et al.. (2001). Treatment of Kasabach-Merritt syndrome by embolisation of a giant liver hemangioma. American Journal of Hematology. 66(2). 140–141. 14 indexed citations
8.
Ladetto, Marco, John W. Donovan, Dario Ferrero, et al.. (2001). A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. Experimental Hematology. 29(2). 183–193. 50 indexed citations
9.
10.
Santini, Gino, P Coser, Luigi Salvagno, et al.. (2000). VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group.. PubMed. 85(2). 160–6. 11 indexed citations
11.
Bassan, Renato, Enrico Pogliani, Teresa Lerede, et al.. (1999). Fractionated cyclophosphamide added to the IVAP regimen (idarubicin-vincristine-L-asparaginase-prednisone) could lower the risk of primary refractory disease in T-lineage but not B-lineage acute lymphoblastic leukemia: first results from a phase II clinical study.. PubMed. 84(12). 1088–93. 13 indexed citations
12.
Mitterer, Manfred, Fuat Oduncu, P Fabris, et al.. (1999). The relationship between monoclonal myeloma precursor B cells in the peripheral blood stem cell harvests and the clinical response of multiple myeloma patients. British Journal of Haematology. 106(3). 737–743. 26 indexed citations
13.
Mitterer, Manfred, et al.. (1999). Epstein-Barr virus related hemophagocytic syndrome in a T-cell rich B-cell lymphoma. Annals of Oncology. 10(2). 231–234. 11 indexed citations
14.
Mitterer, Manfred, Norbert Pescosta, Falko Fend, et al.. (1995). Chronic active Epstein‐Barr virus disease in a case of persistent polyclonal B‐cell lymphocytosis. British Journal of Haematology. 90(3). 526–531. 24 indexed citations
15.
Sertoli, M.R., Gino Santini, Teodoro Chisesi, et al.. (1994). MACOP-B versus ProMACE-MOPP in the treatment of advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study Group.. Journal of Clinical Oncology. 12(7). 1366–1374. 31 indexed citations
16.
Chisesi, Teodoro, A. Contu, P Coser, et al.. (1991). Randomized study of chlorambucil (CB) compared to interferon (alfa-2b) combined with CB in low-grade non-Hodgkin's lymphoma: An interim report of a randomized study. European Journal of Cancer and Clinical Oncology. 27. S31–S33. 22 indexed citations
17.
Carella, Angelo Michele, A Congiu, Patrizio Mazza, et al.. (1988). High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.. Journal of Clinical Oncology. 6(9). 1411–1416. 136 indexed citations
18.
19.
Carella, Angelo Michele, Gino Santini, Armando Santoro, et al.. (1985). Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin's disease. European Journal of Cancer and Clinical Oncology. 21(5). 607–613. 32 indexed citations
20.
Coser, P, et al.. (1979). [Successful pregnancy in acute promyelocytic leukaemia (author's transl)].. PubMed. 64(3). 356–61. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E. Papageorgiou Breakdown of academic impact, for papers by C.F. LeMaistre Breakdown of academic impact, for papers by Jean-Philippe Laporte Breakdown of academic impact, for papers by SH Nantel Breakdown of academic impact, for papers by Mitchell A. Bitter Breakdown of academic impact, for papers by Katsumichi Fujimaki Breakdown of academic impact, for papers by Takafumi Matsushima Breakdown of academic impact, for papers by J. L. Harousseau Breakdown of academic impact, for papers by G. J. Ossenkoppele Breakdown of academic impact, for papers by G. Nedellec
Rankless by CCL
2026